Knight Therapeutics (GUD.TO) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.02
0.02
0.07
0.11

Details

Expected EPS
0.00524269426088
Actual EPS
0.019345735279999998
Surprise EPS
0.01
Surprise Percent
+269%

Description

Knight Therapeutics (GUD.TO) has reported earnings of 0.019345735279999998 per share for Q2 2025.

0 Comments

Share your thoughts